• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载有埃罗替尼的壳聚糖纳米粒通过 aptamer AS1411 修饰后实现双重刺激响应性释放用于非小细胞肺癌治疗。

Dual stimuli-responsive release of aptamer AS1411 decorated erlotinib loaded chitosan nanoparticles for non-small-cell lung carcinoma therapy.

机构信息

Department of Medical Biotechnology, College of Biomedical Sciences, Kangwon National University, Chuncheon, 200-701, South Korea.

Department of Marine Bio-Pharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai, 201306, China.

出版信息

Carbohydr Polym. 2020 Oct 1;245:116407. doi: 10.1016/j.carbpol.2020.116407. Epub 2020 May 20.

DOI:10.1016/j.carbpol.2020.116407
PMID:32718591
Abstract

The present work was developed the pH dependent-aptamer AS1411 (APT) decorated and erlotinib (En) loaded chitosan nanoparticles (CSNPs) for promising non-small-cell lung carcinoma (NSCLC) treatment. The characterization studies revealed that formulated APT-En-CSNPs were spherical in shape with size of 165.95 d. nm and PDI of 0.212. FTIR spectrum recorded molecular chemical interactions with composition of En or En-CSNPs. Cell viability assay, flow cytometry and fluorescent microscopy results revealed that APT-En-CSNPs triggered cancer cell death through pH-sensitive and nucleolin receptor-targeted release of En. The decoration of the APT improved the cellular uptake of En as evidenced by cellular sensing fluorescence and BioTEM assay. The APT-En-CSNPs induced the apoptosis through excessive ROS generation, nucleus damage and Δψm loss in the A549 cells. Hence, the present study revealed that the APT-En-CSNPs improved the therapeutic efficiency of En in NSCLC through the nucleolin targeted drug release.

摘要

本工作开发了 pH 响应适体 AS1411(APT)修饰和厄洛替尼(En)负载壳聚糖纳米粒(CSNPs),用于有前景的非小细胞肺癌(NSCLC)治疗。表征研究表明,所制备的 APT-En-CSNPs 呈球形,粒径为 165.95 d。nm 和 PDI 为 0.212。FTIR 光谱记录了分子化学相互作用以及 En 或 En-CSNPs 的组成。细胞活力测定、流式细胞术和荧光显微镜结果表明,APT-En-CSNPs 通过 pH 敏感和核仁素受体靶向释放 En 触发癌细胞死亡。APT 的修饰提高了 En 的细胞摄取,这可以通过细胞感应荧光和 BioTEM 试验证明。APT-En-CSNPs 通过过量 ROS 生成、细胞核损伤和 Δψm 在 A549 细胞中的损失诱导细胞凋亡。因此,本研究表明,APT-En-CSNPs 通过核仁素靶向药物释放提高了 NSCLC 中 En 的治疗效果。

相似文献

1
Dual stimuli-responsive release of aptamer AS1411 decorated erlotinib loaded chitosan nanoparticles for non-small-cell lung carcinoma therapy.载有埃罗替尼的壳聚糖纳米粒通过 aptamer AS1411 修饰后实现双重刺激响应性释放用于非小细胞肺癌治疗。
Carbohydr Polym. 2020 Oct 1;245:116407. doi: 10.1016/j.carbpol.2020.116407. Epub 2020 May 20.
2
Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.载多柔比星的具有 pH 响应性和适体功能化的聚合物(聚 D,L-乳酸-共-乙醇酸)纳米粒增强癌症治疗。
Arch Biochem Biophys. 2019 Aug 15;671:143-151. doi: 10.1016/j.abb.2019.07.004. Epub 2019 Jul 5.
3
AS1411 Aptamer-Decorated Biodegradable Polyethylene Glycol-Poly(lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non-Small Cell Lung Cancer In Vitro.AS1411适配体修饰的可生物降解聚乙二醇-聚(乳酸-乙醇酸)纳米聚合物囊泡用于吉西他滨体外靶向递送至非小细胞肺癌
J Pharm Sci. 2016 May;105(5):1741-1750. doi: 10.1016/j.xphs.2016.02.021. Epub 2016 Mar 30.
4
Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.pH 敏感荷电转换纳米载体共递送厄洛替尼和阿霉素用于协同治疗。
J Control Release. 2016 May 10;229:80-92. doi: 10.1016/j.jconrel.2016.03.001. Epub 2016 Mar 3.
5
Chloroquine in combination with aptamer-modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin shRNA co-delivery to overcome drug resistance in EGFR-mutated non-small cell lung cancer.氯喹联合适体修饰的纳米复合物用于肿瘤血管正常化和高效厄洛替尼/Survivin shRNA 共递药以克服 EGFR 突变非小细胞肺癌的耐药性。
Acta Biomater. 2018 Aug;76:257-274. doi: 10.1016/j.actbio.2018.06.034. Epub 2018 Jun 28.
6
Aptamer-Conjugated Chitosan-Anchored Liposomal Complexes for Targeted Delivery of Erlotinib to EGFR-Mutated Lung Cancer Cells.用于将厄洛替尼靶向递送至表皮生长因子受体(EGFR)突变肺癌细胞的适配体共轭壳聚糖锚定脂质体复合物
AAPS J. 2017 May;19(3):814-826. doi: 10.1208/s12248-017-0057-9. Epub 2017 Feb 23.
7
Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.用于非小细胞肺癌中厄洛替尼递送的核壳型脂质-聚合物杂化纳米颗粒的研发及体外评价
Eur J Pharm Sci. 2016 Jan 1;81:162-71. doi: 10.1016/j.ejps.2015.10.021. Epub 2015 Oct 27.
8
Combination Chemotherapy of Lung Cancer - Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid-Polymer Hybrid Nanoparticles.肺癌联合化疗——利用适配体修饰的脂质-聚合物杂化纳米粒共递送多西他赛前药和顺铂。
Drug Des Devel Ther. 2020 Jun 9;14:2249-2261. doi: 10.2147/DDDT.S246574. eCollection 2020.
9
Targeted delivery system using silica nanoparticles coated with chitosan and AS1411 for combination therapy of doxorubicin and antimiR-21.载有阿霉素和抗 miR-21 的壳聚糖和 AS1411 修饰的二氧化硅纳米靶向递药系统用于联合治疗。
Carbohydr Polym. 2021 Aug 15;266:118111. doi: 10.1016/j.carbpol.2021.118111. Epub 2021 Apr 24.
10
Aptamer-Functionalized and Backbone Redox-Responsive Hyperbranched Polymer for Targeted Drug Delivery in Cancer Therapy.用于癌症治疗中靶向给药的适体功能化且主链具有氧化还原响应性的超支化聚合物
Biomacromolecules. 2016 Jun 13;17(6):2050-62. doi: 10.1021/acs.biomac.6b00262. Epub 2016 May 4.

引用本文的文献

1
An aptamer-conjugated mesoporous polydopamine formulation for synergistic targeted and photothermal therapy of hepatocellular carcinoma.一种用于肝细胞癌协同靶向和光热治疗的适配体共轭介孔聚多巴胺制剂。
Int J Pharm X. 2025 Apr 24;9:100335. doi: 10.1016/j.ijpx.2025.100335. eCollection 2025 Jun.
2
Surface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting.用于癌症主动靶向的抗表皮生长因子受体(EGFR)配体修饰纳米载体的表面功能化
Nanomaterials (Basel). 2025 Jan 21;15(3):158. doi: 10.3390/nano15030158.
3
Beyond biomarkers: Exploring the diverse potential of a novel phosphoprotein in lung cancer management.
超越生物标志物:探索新型磷酸化蛋白在肺癌管理中的多样潜能。
J Cell Mol Med. 2024 Sep;28(18):e70077. doi: 10.1111/jcmm.70077.
4
Current advance of nanotechnology in diagnosis and treatment for malignant tumors.纳米技术在恶性肿瘤诊断与治疗中的最新进展。
Signal Transduct Target Ther. 2024 Aug 12;9(1):200. doi: 10.1038/s41392-024-01889-y.
5
Aptamers as an approach to targeted cancer therapy.适配体作为一种靶向癌症治疗的方法。
Cancer Cell Int. 2024 Mar 16;24(1):108. doi: 10.1186/s12935-024-03295-4.
6
Anti-nucleolin aptamer AS1411: an advancing therapeutic.抗核仁素适配体AS1411:一种不断发展的治疗药物。
Front Mol Biosci. 2023 Sep 21;10:1217769. doi: 10.3389/fmolb.2023.1217769. eCollection 2023.
7
DNA-Based Nanomaterials as Drug Delivery Platforms for Increasing the Effect of Drugs in Tumors.基于DNA的纳米材料作为药物递送平台以增强药物在肿瘤中的疗效。
Cancers (Basel). 2023 Apr 5;15(7):2151. doi: 10.3390/cancers15072151.
8
Application of aptamer functionalized nanomaterials in targeting therapeutics of typical tumors.适体功能化纳米材料在典型肿瘤靶向治疗中的应用
Front Bioeng Biotechnol. 2023 Feb 16;11:1092901. doi: 10.3389/fbioe.2023.1092901. eCollection 2023.
9
Chitosan as an Outstanding Polysaccharide Improving Health-Commodities of Humans and Environmental Protection.壳聚糖作为一种卓越的多糖,可改善人类健康产品并保护环境。
Polymers (Basel). 2023 Jan 19;15(3):526. doi: 10.3390/polym15030526.
10
Fabrication of a Dual-Drug-Loaded Smart Niosome-g-Chitosan Polymeric Platform for Lung Cancer Treatment.用于肺癌治疗的双药负载智能脂质体-g-壳聚糖聚合物平台的制备
Polymers (Basel). 2023 Jan 6;15(2):298. doi: 10.3390/polym15020298.